All Press Releases
THE LAST DAY OF TRADING IN UNIT RIGHTS IN PILA PHARMA’S RIGHTS ISSUE OF UNITS
Malmö, 10 July 2025 Today, July 10, 2025, is the last day of trading in unit rights issued in connection with PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") rights issue of units which the Board of Directors resolved on June 19, 2025, with authorization from the annual general meeting held 29 April 2025 (the "Rights Issue"). THIS PRESS RELEASE…
PILA PHARMA: INVESTMENT PODCAST GÖTT TJÖT OM AKTIER INTERVIEWS CEO ABOUT RIGHTS ISSUE AND OBESITY ASPIRATIONS
Malmö, 09 July 2025 PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, are delighted to inform investors and others with interest in the space of the participation in a new podcast episode, released July 07, 2025. The podcast segment is recorded in English! Together…
PILA PHARMA: FINWIRE SIT-DOWN INTERVIEW TALKING FUNDRAISING AND BET ON OBESITY
Malmö, 08 July 2025 PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, informs investors and others with interest in the space of a short sit-down in connection to its ongoing rights issue that will finance a new venture in pure obesity studies. …